Prasco Laboratories has entered into a marketing and distribution agreement with GlaxoSmithKline for generic Flonase Nasal Spray. Prasco, as GSK’s agent and on GSK’s behalf, will market and distribute Fluticasone Propionate Nasal Spray to all trade classes in the U.S. under a GSK/Prasco label. “We are especially proud to have established this relationship with GSK, a global leader in the research-based pharmaceutical industry,” said Prasco chief executive officer E. Thomas Arington. “We look ...